Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. The approval of catumaxomab (anti-EpCAM and anti-CD3) and blinatumomab (anti-CD19 and anti-CD3) has become a major milestone in the development of bsAbs. Currently, more than 60 different bsAb formats exist, some of them making their way into the clinical pipeline. This review summarizes diverse formats of bsAbs and their clinical applications and sheds light on strategies to optimize the design of bsAbs.
This report contains market size and forecasts of Bispecific Antibody Therapeutic in global, including the following market information:
Global Bispecific Antibody Therapeutic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Bispecific Antibody Therapeutic Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Bispecific Antibody Therapeutic companies in 2021 (%)
The global Bispecific Antibody Therapeutic market was valued at 3360.6 million in 2021 and is projected to reach US$ 15810 million by 2028, at a CAGR of 24.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bearing An Fc Region Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bispecific Antibody Therapeutic include Creative-biolabs, PharmAbcine, Sorrento Therapeutics and Patheon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bispecific Antibody Therapeutic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bispecific Antibody Therapeutic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bispecific Antibody Therapeutic Market Segment Percentages, by Type, 2021 (%)
- Bearing An Fc Region
- Lacking An Fc Region
Global Bispecific Antibody Therapeutic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bispecific Antibody Therapeutic Market Segment Percentages, by Application, 2021 (%)
- Osteology
- Pulmonary
- Respiratory Diseases
- Oncology
- Gene Therapy
Global Bispecific Antibody Therapeutic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Bispecific Antibody Therapeutic Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bispecific Antibody Therapeutic revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Bispecific Antibody Therapeutic revenues share in global market, 2021 (%)
Key companies Bispecific Antibody Therapeutic sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Bispecific Antibody Therapeutic sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Creative-biolabs
- PharmAbcine
- Sorrento Therapeutics
- Patheon
Bispecific Antibody Therapeutic Market, Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bispecific Antibody Therapeutic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bispecific Antibody Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bispecific Antibody Therapeutic Overall Market Size
2.1 Global Bispecific Antibody Therapeutic Market Size: 2021 VS 2028
2.2 Global Bispecific Antibody Therapeutic Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bispecific Antibody Therapeutic Sales: 2017-2028
3 Company Landscape
3.1 Top Bispecific Antibody Therapeutic Players in Global Market
3.2 Top Global Bispecific Antibody Therapeutic Companies Ranked by Revenue
3.3 Global Bispecific Antibody Therapeutic Revenue by Companies
3.4 Global Bispecific Antibody Therapeutic Sales by Companies
3.5 Global Bispecific Antibody Therapeutic Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bispecific Antibody Therapeutic Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bispecific Antibody Therapeutic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bispecific Antibody Therapeutic Players in Global Market
3.8.1 List of Global Tier 1 Bispecific Antibody Therapeutic Companies
3.8.2 List of Global Tier 2 and Tier 3 Bispecific Antibody Therapeutic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Bispecific Antibody Therapeutic Market Size Markets, 2021 & 2028
4.1.2 Bearing An Fc Region
4.1.3 Lacking An Fc Region
4.2 By Type - Global Bispecific Antibody Therapeutic Revenue & Forecasts
4.2.1 By Type - Global Bispecific Antibody Therapeutic Revenue, 2017-2022
4.2.2 By Type - Global Bispecific Antibody Therapeutic Revenue, 2023-2028
4.2.3 By Type - Global Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
4.3 By Type - Global Bispecific Antibody Therapeutic Sales & Forecasts
4.3.1 By Type - Global Bispecific Antibody Therapeutic Sales, 2017-2022
4.3.2 By Type - Global Bispecific Antibody Therapeutic Sales, 2023-2028
4.3.3 By Type - Global Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
4.4 By Type - Global Bispecific Antibody Therapeutic Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Bispecific Antibody Therapeutic Market Size, 2021 & 2028
5.1.2 Osteology
5.1.3 Pulmonary
5.1.4 Respiratory Diseases
5.1.5 Oncology
5.1.6 Gene Therapy
5.2 By Application - Global Bispecific Antibody Therapeutic Revenue & Forecasts
5.2.1 By Application - Global Bispecific Antibody Therapeutic Revenue, 2017-2022
5.2.2 By Application - Global Bispecific Antibody Therapeutic Revenue, 2023-2028
5.2.3 By Application - Global Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
5.3 By Application - Global Bispecific Antibody Therapeutic Sales & Forecasts
5.3.1 By Application - Global Bispecific Antibody Therapeutic Sales, 2017-2022
5.3.2 By Application - Global Bispecific Antibody Therapeutic Sales, 2023-2028
5.3.3 By Application - Global Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
5.4 By Application - Global Bispecific Antibody Therapeutic Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Bispecific Antibody Therapeutic Market Size, 2021 & 2028
6.2 By Region - Global Bispecific Antibody Therapeutic Revenue & Forecasts
6.2.1 By Region - Global Bispecific Antibody Therapeutic Revenue, 2017-2022
6.2.2 By Region - Global Bispecific Antibody Therapeutic Revenue, 2023-2028
6.2.3 By Region - Global Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
6.3 By Region - Global Bispecific Antibody Therapeutic Sales & Forecasts
6.3.1 By Region - Global Bispecific Antibody Therapeutic Sales, 2017-2022
6.3.2 By Region - Global Bispecific Antibody Therapeutic Sales, 2023-2028
6.3.3 By Region - Global Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Bispecific Antibody Therapeutic Revenue, 2017-2028
6.4.2 By Country - North America Bispecific Antibody Therapeutic Sales, 2017-2028
6.4.3 US Bispecific Antibody Therapeutic Market Size, 2017-2028
6.4.4 Canada Bispecific Antibody Therapeutic Market Size, 2017-2028
6.4.5 Mexico Bispecific Antibody Therapeutic Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Bispecific Antibody Therapeutic Revenue, 2017-2028
6.5.2 By Country - Europe Bispecific Antibody Therapeutic Sales, 2017-2028
6.5.3 Germany Bispecific Antibody Therapeutic Market Size, 2017-2028
6.5.4 France Bispecific Antibody Therapeutic Market Size, 2017-2028
6.5.5 U.K. Bispecific Antibody Therapeutic Market Size, 2017-2028
6.5.6 Italy Bispecific Antibody Therapeutic Market Size, 2017-2028
6.5.7 Russia Bispecific Antibody Therapeutic Market Size, 2017-2028
6.5.8 Nordic Countries Bispecific Antibody Therapeutic Market Size, 2017-2028
6.5.9 Benelux Bispecific Antibody Therapeutic Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Bispecific Antibody Therapeutic Revenue, 2017-2028
6.6.2 By Region - Asia Bispecific Antibody Therapeutic Sales, 2017-2028
6.6.3 China Bispecific Antibody Therapeutic Market Size, 2017-2028
6.6.4 Japan Bispecific Antibody Therapeutic Market Size, 2017-2028
6.6.5 South Korea Bispecific Antibody Therapeutic Market Size, 2017-2028
6.6.6 Southeast Asia Bispecific Antibody Therapeutic Market Size, 2017-2028
6.6.7 India Bispecific Antibody Therapeutic Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Bispecific Antibody Therapeutic Revenue, 2017-2028
6.7.2 By Country - South America Bispecific Antibody Therapeutic Sales, 2017-2028
6.7.3 Brazil Bispecific Antibody Therapeutic Market Size, 2017-2028
6.7.4 Argentina Bispecific Antibody Therapeutic Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Bispecific Antibody Therapeutic Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Bispecific Antibody Therapeutic Sales, 2017-2028
6.8.3 Turkey Bispecific Antibody Therapeutic Market Size, 2017-2028
6.8.4 Israel Bispecific Antibody Therapeutic Market Size, 2017-2028
6.8.5 Saudi Arabia Bispecific Antibody Therapeutic Market Size, 2017-2028
6.8.6 UAE Bispecific Antibody Therapeutic Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Creative-biolabs
7.1.1 Creative-biolabs Corporate Summary
7.1.2 Creative-biolabs Business Overview
7.1.3 Creative-biolabs Bispecific Antibody Therapeutic Major Product Offerings
7.1.4 Creative-biolabs Bispecific Antibody Therapeutic Sales and Revenue in Global (2017-2022)
7.1.5 Creative-biolabs Key News
7.2 PharmAbcine
7.2.1 PharmAbcine Corporate Summary
7.2.2 PharmAbcine Business Overview
7.2.3 PharmAbcine Bispecific Antibody Therapeutic Major Product Offerings
7.2.4 PharmAbcine Bispecific Antibody Therapeutic Sales and Revenue in Global (2017-2022)
7.2.5 PharmAbcine Key News
7.3 Sorrento Therapeutics
7.3.1 Sorrento Therapeutics Corporate Summary
7.3.2 Sorrento Therapeutics Business Overview
7.3.3 Sorrento Therapeutics Bispecific Antibody Therapeutic Major Product Offerings
7.3.4 Sorrento Therapeutics Bispecific Antibody Therapeutic Sales and Revenue in Global (2017-2022)
7.3.5 Sorrento Therapeutics Key News
7.4 Patheon
7.4.1 Patheon Corporate Summary
7.4.2 Patheon Business Overview
7.4.3 Patheon Bispecific Antibody Therapeutic Major Product Offerings
7.4.4 Patheon Bispecific Antibody Therapeutic Sales and Revenue in Global (2017-2022)
7.4.5 Patheon Key News
8 Global Bispecific Antibody Therapeutic Production Capacity, Analysis
8.1 Global Bispecific Antibody Therapeutic Production Capacity, 2017-2028
8.2 Bispecific Antibody Therapeutic Production Capacity of Key Manufacturers in Global Market
8.3 Global Bispecific Antibody Therapeutic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bispecific Antibody Therapeutic Supply Chain Analysis
10.1 Bispecific Antibody Therapeutic Industry Value Chain
10.2 Bispecific Antibody Therapeutic Upstream Market
10.3 Bispecific Antibody Therapeutic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bispecific Antibody Therapeutic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Bispecific Antibody Therapeutic in Global Market
Table 2. Top Bispecific Antibody Therapeutic Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bispecific Antibody Therapeutic Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bispecific Antibody Therapeutic Revenue Share by Companies, 2017-2022
Table 5. Global Bispecific Antibody Therapeutic Sales by Companies, (K Units), 2017-2022
Table 6. Global Bispecific Antibody Therapeutic Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bispecific Antibody Therapeutic Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Bispecific Antibody Therapeutic Product Type
Table 9. List of Global Tier 1 Bispecific Antibody Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bispecific Antibody Therapeutic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bispecific Antibody Therapeutic Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bispecific Antibody Therapeutic Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bispecific Antibody Therapeutic Sales (K Units), 2017-2022
Table 15. By Type - Global Bispecific Antibody Therapeutic Sales (K Units), 2023-2028
Table 16. By Application - Global Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bispecific Antibody Therapeutic Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bispecific Antibody Therapeutic Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bispecific Antibody Therapeutic Sales (K Units), 2017-2022
Table 20. By Application - Global Bispecific Antibody Therapeutic Sales (K Units), 2023-2028
Table 21. By Region - Global Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bispecific Antibody Therapeutic Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bispecific Antibody Therapeutic Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bispecific Antibody Therapeutic Sales (K Units), 2017-2022
Table 25. By Region - Global Bispecific Antibody Therapeutic Sales (K Units), 2023-2028
Table 26. By Country - North America Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bispecific Antibody Therapeutic Sales, (K Units), 2017-2022
Table 29. By Country - North America Bispecific Antibody Therapeutic Sales, (K Units), 2023-2028
Table 30. By Country - Europe Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bispecific Antibody Therapeutic Sales, (K Units), 2017-2022
Table 33. By Country - Europe Bispecific Antibody Therapeutic Sales, (K Units), 2023-2028
Table 34. By Region - Asia Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bispecific Antibody Therapeutic Sales, (K Units), 2017-2022
Table 37. By Region - Asia Bispecific Antibody Therapeutic Sales, (K Units), 2023-2028
Table 38. By Country - South America Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bispecific Antibody Therapeutic Sales, (K Units), 2017-2022
Table 41. By Country - South America Bispecific Antibody Therapeutic Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bispecific Antibody Therapeutic Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Bispecific Antibody Therapeutic Sales, (K Units), 2023-2028
Table 46. Creative-biolabs Corporate Summary
Table 47. Creative-biolabs Bispecific Antibody Therapeutic Product Offerings
Table 48. Creative-biolabs Bispecific Antibody Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. PharmAbcine Corporate Summary
Table 50. PharmAbcine Bispecific Antibody Therapeutic Product Offerings
Table 51. PharmAbcine Bispecific Antibody Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sorrento Therapeutics Corporate Summary
Table 53. Sorrento Therapeutics Bispecific Antibody Therapeutic Product Offerings
Table 54. Sorrento Therapeutics Bispecific Antibody Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Patheon Corporate Summary
Table 56. Patheon Bispecific Antibody Therapeutic Product Offerings
Table 57. Patheon Bispecific Antibody Therapeutic Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bispecific Antibody Therapeutic Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global Bispecific Antibody Therapeutic Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Bispecific Antibody Therapeutic Production by Region, 2017-2022 (K Units)
Table 61. Global Bispecific Antibody Therapeutic Production by Region, 2023-2028 (K Units)
Table 62. Bispecific Antibody Therapeutic Market Opportunities & Trends in Global Market
Table 63. Bispecific Antibody Therapeutic Market Drivers in Global Market
Table 64. Bispecific Antibody Therapeutic Market Restraints in Global Market
Table 65. Bispecific Antibody Therapeutic Raw Materials
Table 66. Bispecific Antibody Therapeutic Raw Materials Suppliers in Global Market
Table 67. Typical Bispecific Antibody Therapeutic Downstream
Table 68. Bispecific Antibody Therapeutic Downstream Clients in Global Market
Table 69. Bispecific Antibody Therapeutic Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Bispecific Antibody Therapeutic Segment by Type
Figure 2. Bispecific Antibody Therapeutic Segment by Application
Figure 3. Global Bispecific Antibody Therapeutic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bispecific Antibody Therapeutic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bispecific Antibody Therapeutic Revenue, 2017-2028 (US$, Mn)
Figure 7. Bispecific Antibody Therapeutic Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bispecific Antibody Therapeutic Revenue in 2021
Figure 9. By Type - Global Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 10. By Type - Global Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bispecific Antibody Therapeutic Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 13. By Application - Global Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bispecific Antibody Therapeutic Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 16. By Region - Global Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 19. US Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 24. Germany Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 25. France Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 33. China Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 37. India Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 40. Brazil Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bispecific Antibody Therapeutic Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bispecific Antibody Therapeutic Sales Market Share, 2017-2028
Figure 44. Turkey Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bispecific Antibody Therapeutic Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bispecific Antibody Therapeutic Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Bispecific Antibody Therapeutic by Region, 2021 VS 2028
Figure 50. Bispecific Antibody Therapeutic Industry Value Chain
Figure 51. Marketing Channels
Global Antibody Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 136
According to our LPI (LP Information) latest study, the global Antibody market size was valued at US$ 8893.3 million in 2023. With growing demand in downstream market, the Antibody is forecast to a readjusted size of US$ 12940 million by 2030 with a CAGR of 5.5% during review period.
The research report highlights the growth potential of the global Antibody market. Antibody are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
Global Antibody Production Market Status and Outlook 2023-2028
Published: 22-Dec-2023 Price: US 3160 Onwards Pages: 121
Antibody production involves preparation of antigen samples and their safe injection into laboratory or farm animals so as to evoke high expression levels of antigen-specific antibodies in the serum, which can then be recovered from the animal. Polyclonal antibodies are recovered directly from serum (bleeds).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (mil......
Global Antibody Production Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 21-Dec-2023 Price: US 3380 Onwards Pages: 100
Market Overview of Global Antibody Production market:
According to our latest research, the global Antibody Production market looks promising in the next 5 years. As of 2022, the global Antibody Production market was estimated at USD 9193.37 million, and it's anticipated to reach USD 17140.24 million in 2028, with a CAGR of 10.94% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
Global Antibody Production Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 117
Report Overview:
The Global Antibody Production Market Size was estimated at USD 8847.90 million in 2022 and is projected to reach USD 14207.79 million by 2029, exhibiting a CAGR of 7.00% during the forecast period.
This report provides a deep insight into the global Antibody Production market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key mark......
Global Anti-CD20 Monoclonal Antibodies Professional Survey Report 2023, Forecast to 2028
Published: 30-Nov-2023 Price: US 3280 Onwards Pages: 100
Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
Global Anti-CD20 Monoclonal Antibodies Market Research Report 2023, Forecast to 2028
Published: 30-Nov-2023 Price: US 2680 Onwards Pages: 165
Anti-CD20 monoclonal antibodies (mAbs) are used to achieve B cell depletion, and were initially developed to treat B cell proliferative disorders, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all th......
Monoclonal Antibody Industry Forecasts - China Focus
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 92
This study focuses on China's Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and services.......
Monoclonal Antibody Companies in China
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 73
This study focuses on China's Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions......
Monoclonal Antibody Markets in China
Published: 27-Nov-2023 Price: US 4000 Onwards Pages: 219
China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, i......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
